[Management of atrial fibrillation comorbid with coronary heart disease].

Seiji Takatsuki

Research output: Contribution to journalReview articlepeer-review


Atrial fibrillation (AF) and coronary artery disease (CAD) can be comorbid with each other, because they can develop based on common risk factors such as aging, hypertension, diabetes mellitus and obesity. The management for stroke prevention in patients with AF and CAD needs some cautions. The vascular disease including CAD has been approved as one of the risk developing stroke in the CHA2DS2-VASc score for patients with AF. Patients with AF and CAD often should take antiplatelet and anticoagulant and sometimes take double antiplatelets and anticoagulant, which associates with increased bleeding risk. On terms of the management of AF, the medications of the rhythm control therapy for the AF would be limited if a patient has CAD. A K channel blocker would be selected for the 1st line therapy.

Original languageEnglish
Pages (from-to)142-147
Number of pages6
JournalUnknown Journal
Issue number1
Publication statusPublished - 2013 Jan

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of '[Management of atrial fibrillation comorbid with coronary heart disease].'. Together they form a unique fingerprint.

Cite this